Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer

Wenwen Xue(Nanjing Drum Tower Hospital), Qiang Xu(China Pharmaceutical University), Yingyan Yu(Fujian Medical University), Chengfei Jiang(National Heart Lung and Blood Institute), Wuhao Li(Nanjing University), Yan Shen(Zhejiang Chinese Medical University), Yixuan Wang(Fudan University), Xin Li(Nanjing University), Lin Zhou(Xiamen University), Jian Gao(Hebei Medical University)
Signal Transduction and Targeted Therapy
February 4, 2022
Cited by 29


Related Papers